跳至主要内容
临床试验/CTRI/2022/01/039603
CTRI/2022/01/039603尚未招募2 期

Clinical study of Hasah-al-kuliya(Nephrolithiasis) and Evaluation of Therapeutic efficacy of Unani Compound Formulation in its Management.

Central Council of Unani Medicine New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Clinically/ radiologically diagnosed patients of Hasah-e-Kulya (Nephrolithiasis) from size 5 to 10mm.
  • Patients irrespective of gender.
  • Patients between 18 to 60 years of age.
  • Patients who are agreed to sign the informed consent form and follow the protocol.

排除标准

  • Pregnant and lactating women
  • Patients below the age of 18 years and above the age of 60 years.
  • Diabetes Mellitus.
  • Hydronephrosis grade II and above
  • Poorly controlled Hypertension.
  • Significant Liver and Renal dysfunction.
  • Cardiovascular diseases.
  • Unwillingness or inability to sign consent form.
  • A medical condition that in the investigatorâ??s opinion would interfere the treatment, safety or adherence to protocol.

研究者

发起方
Central Council of Unani Medicine New Delhi

相似试验